105 related articles for article (PubMed ID: 25278732)
1. Harm reduction.
Normand J; Li JH; Thomson N; Jarlais DD
J Food Drug Anal; 2013 Oct; 21(4):S10-S12. PubMed ID: 25278732
[TBL] [Abstract][Full Text] [Related]
2. HIV: seek, test, treat, and retain.
Normand J; Montaner J; Fang CT; Wu Z; Chen YM
J Food Drug Anal; 2013 Dec; 21(4):S4-S6. PubMed ID: 25278735
[TBL] [Abstract][Full Text] [Related]
3. Brain Abnormalities in HIV and Stimulant Users: Interventions and Prevention.
Chang L; Shoptaw S; Normand J
J Food Drug Anal; 2013 Dec; 21(4):S7-S9. PubMed ID: 25264417
[TBL] [Abstract][Full Text] [Related]
4. Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.
Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Turcotte MÈ; Bruneau J
Am J Prev Med; 2020 Jun; 58(6):845-853. PubMed ID: 32444003
[TBL] [Abstract][Full Text] [Related]
5. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts.
Huang YF; Yang JY; Nelson KE; Kuo HS; Lew-Ting CY; Yang CH; Chen CH; Chang FY; Liu HR
PLoS Med; 2014 Apr; 11(4):e1001625. PubMed ID: 24714449
[TBL] [Abstract][Full Text] [Related]
6. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
7. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
Des Jarlais DC; Feelemyer JP; Modi SN; Abdul-Quader A; Hagan H
BMC Public Health; 2013 Jan; 13():53. PubMed ID: 23332005
[TBL] [Abstract][Full Text] [Related]
8. A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
Marotta PL; McCullagh CA
Int J Drug Policy; 2016 Jun; 32():3-10. PubMed ID: 27212656
[TBL] [Abstract][Full Text] [Related]
9. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
Bonny-Noach H
Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
[TBL] [Abstract][Full Text] [Related]
10. Measures of harm reduction service provision for people who inject drugs.
O'Keefe D; Bluthenthal RN; Kral AH; Aitken CK; McCormack A; Dietze PM
Bull World Health Organ; 2019 Sep; 97(9):605-611. PubMed ID: 31474773
[TBL] [Abstract][Full Text] [Related]
11. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
12. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
[TBL] [Abstract][Full Text] [Related]
13. "I held on to the police's leg for mercy": Experiences of adversity, risk and harm among people who inject drugs during an anti-drug drive in Dhaka, Bangladesh.
Khan SI; Irfan SD; Khan MNM
Int J Drug Policy; 2021 Jun; 92():103299. PubMed ID: 34030931
[TBL] [Abstract][Full Text] [Related]
14. Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.
Colledge S; Leung J; Larney S; Peacock A; Grebely J; Hickman M; Cunningham E; Trickey A; Stone J; Vickerman P; Degenhardt L
Int J Drug Policy; 2020 Feb; 76():102619. PubMed ID: 31864107
[TBL] [Abstract][Full Text] [Related]
15. Effects of combination approach on harm reduction programs: the Taiwan experience.
Lin T; Chen CH; Chou P
Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
[TBL] [Abstract][Full Text] [Related]
16. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.
Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV
Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604
[TBL] [Abstract][Full Text] [Related]
18. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
White B; Haber PS; Day CA
Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
[TBL] [Abstract][Full Text] [Related]
19. Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
O'Keefe D; Aung SM; Pasricha N; Wun T; Linn SK; Lin N; Aitken C; Hughes C; Dietze P
Int J Drug Policy; 2018 Aug; 58():22-30. PubMed ID: 29754104
[TBL] [Abstract][Full Text] [Related]
20. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
